AI assistant
Sending…
Ocugen, Inc. — Director's Dealing 2019
Oct 4, 2019
32915_dirs_2019-10-04_eee5cb65-5212-4045-847a-be1c14223f77.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Ocugen, Inc. (OCGN)
CIK: 0001372299
Period of Report: 2019-09-30
Reporting Person: Zhang Junge (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2019-09-30 | Common Stock | P | 197 | $2.45 | Acquired | 197 | Direct |
| 2019-09-30 | Common Stock | P | 200 | $2.46 | Acquired | 397 | Direct |
| 2019-09-30 | Common Stock | P | 1358 | $2.47 | Acquired | 1755 | Direct |
| 2019-09-30 | Common Stock | P | 100 | $2.45 | Acquired | 1855 | Direct |
| 2019-09-30 | Common Stock | P | 3000 | $2.48 | Acquired | 4855 | Direct |
| 2019-09-30 | Common Stock | P | 660 | $2.50 | Acquired | 5515 | Direct |
| 2019-09-30 | Common Stock | P | 200 | $2.49 | Acquired | 5715 | Direct |
| 2019-09-30 | Common Stock | P | 200 | $2.62 | Acquired | 5915 | Direct |
| 2019-09-30 | Common Stock | P | 10000 | $3.10 | Acquired | 15915 | Direct |
| 2019-09-30 | Common Stock | P | 2000 | $3.35 | Acquired | 17915 | Direct |
| 2019-09-30 | Common Stock | P | 1163 | $3.10 | Acquired | 19078 | Direct |
| 2019-09-30 | Common Stock | P | 2000 | $3.80 | Acquired | 21078 | Direct |
| 2019-09-30 | Common Stock | P | 5000 | $3.35 | Acquired | 26078 | Direct |
| 2019-09-30 | Common Stock | P | 3000 | $3.30 | Acquired | 29078 | Direct |
| 2019-09-30 | Common Stock | P | 2000 | $2.95 | Acquired | 31078 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 212863 | Indirect |
More from Ocugen, Inc.
Regulatory Filings
2026
May 14
Regulatory Filings
2026
May 14
Regulatory Filings
2026
May 5
Regulatory Filings
2026
May 4
Annual Report
2026
Apr 28
Major Shareholding Notification
2026
Mar 27
Regulatory Filings
2026
Mar 24
Regulatory Filings
2026
Mar 20
Annual Report
2026
Mar 4
Regulatory Filings
2026
Mar 4